Market Cap | 47.52M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -1.03M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -1.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 3.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -9.00% |
Recommedations | - | Quick Ratio | 0.18 | Shares Outstanding | 4.34M | 52W Low Chg | 9.00% |
Insider Own | 44.98% | ROA | -1.82% | Shares Float | 1.10M | Beta | - |
Inst Own | 67.66% | ROE | - | Shares Shorted/Prior | 27/27 | Price | 10.96 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 7,448 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 4 | Change | -0.36% |
Monterey Innovation Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Monterey Bio Acquisition Corporation and changed its name to Monterey Innovation Acquisition Corp. in March 2023. The company was incorporated in 2020 and is based in New York, New York.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Chardan Monterey Investments L... | 10% Owner 10% Owner | Mar 09 | Sell | 0.01 | 13,125 | 131 | 624,375 | 04/11/23 |
Chardan Monterey Investments L... | 10% Owner 10% Owner | Mar 09 | Buy | 0.01 | 478,125 | 4,781 | 1,102,500 | 04/11/23 |
GROSSMAN JONAS | Director Director | Mar 09 | Sell | 0.01 | 13,125 | 131 | 624,375 | 03/13/23 |
GROSSMAN JONAS | Director Director | Mar 09 | Buy | 0.01 | 478,125 | 4,781 | 1,102,500 | 03/13/23 |
NORTHSTAR BIO VENTURES, LLC | 10% Owner 10% Owner | Mar 09 | Sell | 0.01 | 570,000 | 5,700 | 1,342,500 | 03/13/23 |
Patel Sandip I | Director Director | Mar 09 | Sell | 0.01 | 570,000 | 5,700 | 1,342,500 | 03/13/23 |